Cellular responses to a prolonged delay in mitosis are determined by a DNA damage response controlled by Bcl-2 family proteins

Open Biology
Didier J ColinPaul R Clarke

Abstract

Anti-cancer drugs that disrupt mitosis inhibit cell proliferation and induce apoptosis, although the mechanisms of these responses are poorly understood. Here, we characterize a mitotic stress response that determines cell fate in response to microtubule poisons. We show that mitotic arrest induced by these drugs produces a temporally controlled DNA damage response (DDR) characterized by the caspase-dependent formation of γH2AX foci in non-apoptotic cells. Following exit from a delayed mitosis, this initial response results in activation of DDR protein kinases, phosphorylation of the tumour suppressor p53 and a delay in subsequent cell cycle progression. We show that this response is controlled by Mcl-1, a regulator of caspase activation that becomes degraded during mitotic arrest. Chemical inhibition of Mcl-1 and the related proteins Bcl-2 and Bcl-xL by a BH3 mimetic enhances the mitotic DDR, promotes p53 activation and inhibits subsequent cell cycle progression. We also show that inhibitors of DDR protein kinases as well as BH3 mimetics promote apoptosis synergistically with taxol (paclitaxel) in a variety of cancer cell lines. Our work demonstrates the role of mitotic DNA damage responses in determining cell fate in response...Continue Reading

References

Apr 12, 2002·Cancer Genetics and Cytogenetics·Yong-Bum ParkJun Yokota
Feb 17, 2007·Cell Death and Differentiation·D CrightonK M Ryan
May 1, 2007·Molecular Cell·Lindsey A Allan, Paul R Clarke
Nov 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mai NguyenGordon C Shore
May 3, 2008·Cancer Research·Christin TseSteven W Elmore
May 13, 2008·Nature Cell Biology·Zhenye YangConly L Rieder
Jan 27, 2009·Trends in Cell Biology·Paul R Clarke, Lindsey A Allan
Jun 11, 2009·Molecular Cancer Therapeutics·Michael E BekierWilliam R Taylor
Sep 5, 2009·The EMBO Journal·Joshua L AndersenSally Kornbluth
Oct 6, 2009·Cancer Cell·Hsiao-Chun HuangTimothy J Mitchison
Oct 23, 2009·Nature·Stephen P Jackson, Jiri Bartek
Dec 23, 2009·The Journal of Cell Biology·Sairei SoDavid J Chen
May 25, 2010·Developmental Cell·Stephen W G TaitDouglas R Green
Jul 28, 2010·The Journal of Cell Biology·Simona GiuntaStephen P Jackson
Sep 14, 2010·Current Biology : CB·Yumi Uetake, Greenfield Sluder
May 10, 2011·Nature Structural & Molecular Biology·Luis I ToledoOscar Fernandez-Capetillo
Sep 1, 2011·Journal of Cell Science·Gabriela ImrehBoris Zhivotovsky
Dec 16, 2011·Molecular Biology of the Cell·James D OrthTimothy J Mitchison
Jan 20, 2012·Nature·Karen CrastaDavid Pellman
Mar 13, 2012·Nature Structural & Molecular Biology·Makoto T HayashiJan Karlseder
Dec 22, 2012·Nature Reviews. Molecular Cell Biology·Emily A Foley, Tarun M Kapoor
Jul 6, 2013·Cell·Emily M HatchMartin W Hetzer
Mar 22, 2014·Science·Alexandre OrthweinDaniel Durocher

❮ Previous
Next ❯

Citations

May 4, 2016·British Journal of Cancer·Joanna L Fox, Marion MacFarlane
Jul 2, 2016·Nature Reviews. Cancer·Gabriel Ichim, Stephen W G Tait
Aug 3, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Joana FonsecaHassan Bousbaa
Aug 12, 2016·Open Biology·Ailsa BennettStephen S Taylor
Oct 19, 2016·British Journal of Clinical Pharmacology·Darcy Bates, Alan Eastman
Mar 6, 2019·Diabetes·Rohit B SharmaLaura C Alonso
Apr 16, 2020·Acta Neuropathologica Communications·Alexander SosunovJames E Goldman
Jan 16, 2016·Oncotarget·Olivia SlossStephen Taylor
Sep 5, 2020·Molecular Carcinogenesis·Zina SarifJürgen Eberle
Jul 25, 2015·The Biochemical Journal·David W Meek
Jun 14, 2018·Scientific Reports·Alexander LorzDoron Levy
Dec 14, 2018·Molecular & Cellular Oncology·Paul R ClarkeAgnieszka Skowyra
Dec 9, 2016·Journal of Cell Science·Ying HouPaul R Clarke
Sep 16, 2017·Frontiers in Oncology·Alexander LorzDoron Levy
Aug 24, 2017·Environmental and Molecular Mutagenesis·Ion UdroiuAntonella Sgura
Aug 23, 2018·Molecular Biology of the Cell·Yumi Uetake, Greenfield Sluder
Feb 16, 2021·Frontiers in Pharmacology·Haruna EbisuTakeo Usui
Jul 3, 2021·International Journal of Molecular Sciences·Christine J Hawkins, Mark A Miles
Jun 16, 2021·Biochemical Pharmacology·Alfonso Serrano-Del ValleIsabel Marzo

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
flow cytometry

Software Mentioned

Microsoft E xcel
Adobe P hotoshop
Graphpad P rism
Adobe I llustrator

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis